Searched for
ANTIRETROVIRAL
Brokerages stay bullish on Laurus Labs as CDMO momentum and margins improveLaurus Labs' stock has surged 30% on robust FY26 results, fueled by a booming contract manufacturing business and improved product mix. The...
Aurobindo Pharma Q3 net profit drops 10% to Rs 846 croreAurobindo Pharma reported a 10% YoY decline in net profit to Rs 846 crore for Q3FY25, mainly due to a decrease in US sales. However, the co...
World AIDS Day 2024: AIDS and HIV are often confused as the same disease. Debunking the popular mythWorld AIDS Day 2024: Thanks to advancements in treatment, HIV is no longer a death sentence. By adhering to antiretroviral therapy, people ...
How drugs were used to spread HIV among 800+ students in TripuraTripura is grappling with a severe HIV outbreak among its student population, exacerbated by injectable drug use. According to Tripura Stat...
Adequate stock of antiretroviral drugs for 95% 'People Living with HIV' in India: SourcesThere is no reported stock out for any antiretroviral (ARV) drugs at the state level and fresh supply orders for procurement of the next lo...
Cipla, DNDi launch 4-in-1 antiretroviral treatment for children with HIVSouth African Health Products Regulatory Authority (SAHPRA) has approved the sweet-tasting, heat-stable and '4-in-1' fixed-dose combination...
Kerala: British national given HIV antiretroviral drugs to treat coronavirus now tests negativeA British national, who was administered HIV antiretroviral drugs for treating his coronavirus infection, has tested negative, doctors at t...
Pharma department tells companies to step up manufacture of anti-HIV drugsExperts meets pharma execs seeking enough stock of Lopinavir and Ritonavir to be kept ready for India.
Battling the epidemic: India readies treatment protocol for CoronavirusThe Indian Council of Medical Research (ICMR) has approval from the Drug Controller General of India (DCGI) to allow a combination of lopin...
Young HIV patients can now live a normal life with the help of new drugsA 20-year-old who began therapy in 2008 can now live up to 78 years, says a new study.
India calls for flexibilities in IPR to combat AIDSJP Nadda said India will need to "front load" its investments substantially to almost double the number of people on ARV treatment in less ...
Asia-Pacific region faces epidemic of HIV among adolescents: UNIndia, China and Pakistan are among the 10 countries in the Asia-Pacific that account for 98% of youngsters aged 10 to 19 living with HIV.
HIV breakthrough: FDA approves new drug with fewer side effectsA new treatment for HIV infection has been approved by US federal regulators which does not have the side effects associated with other dru...
New HIV infections down by 20 per cent in India: UN reportIndia has been able to achieve a more than 20% decline in new HIV infections between 2000 and 2014, according to a UN report.
Cipla awarded $188.95 million tender by Global Fund for ARV drugs to treat HIV/AIDSCipla has been awarded $188.95 million tender for anti-retrovirals drugs by Global Fund which would enable it to supply the medicines to ov...
HIV Bill: Panel will be apprised on demands, says TNHealth Secretary J Radhakrishnan refuted claims that there was a shortage of Antiretroviral Therapy Drugs (ART) in Tamil Nadu.
HIV losing its edge, evolving into milder form: StudyOne of the world's most feared virus is losing its edge. HIV is evolving to become less deadly and less infectious, according to a major sc...
New therapy may offer HIV cureScientists used radioimmunotherapy to destroy remaining human immunodeficiency virus -infected cells in the blood samples of patients treat...
- Activists delivers coffin to Novartis over Indian case
The groups said India's ability to manufacture low cost generic versions of newer medicines would be threatened if Norvatis won the suit.
- Aurobindo gets USFDA nod for anti-HIV drug
Aurobindo Pharma Ltd on Wednesday said it has received tentative approval by USFDA for its anti-HIV drug, Didanosine chewable tablets of 10...